Cavex ImpreSafe effective against modern threats

Cavex continuously performs efficacy tests, providing sufficient evidence to guarantee safe impressions after disinfection with Cavex ImpreSafe.

Starting out as a hospital infection, MRSA has now emerged as a broader community risk. Being resistant to antibiotics, Methicillin-Resistant Staphylococcus Aureus (MRSA) is responsible for several difficult-to-treat infections in humans. Efficacy testing with Cavex ImpreSafe disinfection against MRSA showed >5.0 log reduction under clean and dirty (0.3% albumin – artificial blood) conditions after a contact time of 1 minute at a test temperature of 20°C.

Norovirus became world news during the 2018 Winter Olympics in Korea. The virus usually spreads via the fecal-oral route, by contaminated food or water, person-to-person contact, contaminated surfaces or through the air. Efficacy of Cavex ImpreSafe against the Murine norovirus strain S99 Berlin is tested under clean conditions at 20°C.  The required log 4 reduction was achieved after a contact time of 2 minutes at a test temperature of 20°C.

In conclusion, 
the prescribed 3-minute disinfection with Cavex ImpreSafe is highly effective against both MRSA bacteria and Norovirus, showing the microbial reduction as required by the relevant standards. Copies of the full test reports are available on request at

Website design & development by Picturae